An increase in updated glucose over the complete study period by. Mortality prediction in diabetic patients with myocardial infarction. Digami 2independent baseline predictors for death including updated fasting glucose values. Actually, the digami study has brought too many criticisms, such as the uncertainty whether the gik infusion during ami or the followed longterm insulin treatment caused the favorable longterm outcome, the small simple size, large confident intervals and the potential bias resulted with only the 50% of all eligible patients being randomized. Diabetic cardiology pdf free pdf epub medical books. Prognostic implications of glucoselowering treatment in patients with acute myocardial infarction and diabetes. Why does this approach raise such a serious concern. Subsequent studies digami 2 n 1,253 46 and the hi5 hyperglycemia. Concomitant treatment with regard to the open study design, the protocol stated that the use of concomitant treatment should be as uniform as possible and according to evidencebased international. In the first digami study, an insulinbased glucose. Download fulltext pdf download fulltext pdf mannosebinding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction.
Only with adobe acrobat reader you can view, sign, collect and track feedback, and share pdfs for. Glucose control was to be achieved through an insulindextrose infusion with a variable rate of insulin. Hyperglycemia at the time of hospital admission predicts increased mortality in patients with acute coronary syndromes acs, including stsegment elevation myocardial infarction stemi 16, revascularization procedures such as thrombolysis or percutaneous coronary intervention pci 710, and other critical illnesses 11. Importantly, the varying glucose target levels of these studies make it di. Before randomization, the patients were stratified into 4 groups on the basis of risk. The digami study on the use of intravenous insulin infusion atthe time of myocardial infarction mi has stimulated a largenumber of discussion papers on the best treatment of mi in thediabetic patient. The nature of the study, a truly investigatorinitiated trial, rendered it a lowbudget trial despite generous research grants. The digami study published in 1995 reignited interest in the use of insulin following acute mi. Say no to diabetes available for download and read online in other formats. Nov 17, 2014 management of acute coronary syndrome in special subgroups. The diabetes insulinglucose in acute myocardial infarction digami trial demonstrated significant reductions in mortality when an intensive insulin regimen was administered to hyperglycemic patients hospitalized with acute mi. In the first digami study, an insulinbased glucose management.
Admissionhyperglycemia andacutemyocardialinfarction. These abnormalities can be detected early in the postinfarction period. Subsequent studiesdigami2 n 1,253 46 and the hi5 hyperglycemia. The evidence base included one study where 50% of the study population had an admission glucose lower than the value accepted by the working group to define hyperglycaemia,7 and another in which the mean admission blood glucose was 8. Download free acrobat reader dc software, the only pdf viewer that lets you read, search, print, and interact with virtually any type of pdf file. The relationship between blood glucose and mortality. Experience from the code study 18 and registries 19 does indeed. Antihyperglycemic drugs and cardiovascular outcomes in. Importantly, the varying glucose target levels of these studies make it difficult to compare their results and infer a firm conclusion. While the digami study was able to demonstrate a decrease in both mortality and mean 24hour blood glucose levels, the digami 2 and hi5 studies showed no such significant decrease figure 2 2729. Its the only pdf viewer that can open and interact with all types of pdf content, including.
Impact of hyperglycemia on longterm outcome in patients with. Among the spectral domain measures, after adjustment for age, sex, baseline hrv measure, history of myocardial infarction, bmi at study exit, physical activity level at study exit, and baseline depression and anger scores, there was a statistically significant difference in. Selfrated health predicts outcome in patients with type 2 diabetes and myocardial infarction. In four highdose gik studies 288 patients, differences in mortality were not statistically significant. Adobe acrobat reader dc software is the free global standard for reliably viewing, printing, and commenting on pdf documents.
The interpretation of digami 2 is that for a similar glycaemic control insulin treatment is not superior to the use of other therapeutic options as regards mortality. In animal studies, infarct size was linearly related to blood glucose concentration during acute. On the basis of these findings, the diabetes mellitus insulin glucose infusion in acute myocardial infarction digami 1 trial was started. Intense metabolic control by means of insulin in patients with. Pdf mannosebinding lectin genotype and phenotype in. It is important to note, however, that the digami study did identify the benefit of strict glycaemic control in patients with ami. Pdf say no to diabetes download full pdf book download. Digami 2 was designed to test whether intense metabolic control by means of insulin was able to reduce mortality following acute myocardial infarction. It is well established that hyperglycaemia is common in patients admitted to the hospital with acute coronary syndrome acs, and is an an independent risk factor for adverse outcome. Intensive insulin infusion in infarction study n 240, 47 both investigating the effects of intensive insulin therapy in patients with type 2 diabetes and mishowed no significant effects on mortality in patients at 1 year digami2 and 6 months hi5. The prevalence of diabetes mellitus in patients requiring cardiac surgery is rapidly increasing. Bode, md, face atlanta diabetes associates atlanta, georgia hyperglycemia in hospitalized patients hyperglycemia occurred in 38% of hospitalized patients 26% had known history of diabetes 12% had no history of diabetes newly discovered hyperglycemia was associated with. In diabetics who have had an mi, the digami study showed that intravenous insulin for 24 hours and subcutaneous insulin for 3 months improved mortality rates for up to 3 years after. The digami diabetes mellitus, insulin glucose infusion in.
Endocrinologymetabolismdiabetes mellitus medical books free. We studied the 865 patients who survived during 12 months without any change in their glucose. Our results suggest that fasting and postchallenge hyperglycaemia in the early phase of an acute myocardial infarction could be used as early markers of highrisk individuals. The power calculation indicated that 3,000 patients would be required, but despite intense efforts at recruitment only 1,253 patients had been randomised after 5 years, and the steering committee stopped the trial. Our findings show that the small bites suture technique is more effective than the traditional large bites technique for prevention of incisional hernia in midline incisions and is not associated with a higher rate of adverse events. While the digami study was able to demonstrate a decrease in both mortality and mean 24hour blood glucose levels, the digami2 and hi5 studies showed no such significant decrease figure 2 2729. The evidencebased reduction in risk of microvascular disease with glucose lowering has resulted in guidelines worldwide. Hyperglycaemia in critically ill patients amsterdam umc vrije. The study conformed to good clinical practice guidelines and followed the recommendations of the helsinki declaration. The subsequent digami 2 study malmberg et al, 2005 sought to answer queries raised by the original study but was also controversial. Exclusion criteria were inability to cope with insulin treatment or to receive information on the study. Management of hyperglycemia and diabetes in the hospital.
This post hoc analysis from the diabetes mellitus insulinglucose infusion in acute myocardial infarction digami 2 trial reports on extended. The digami study underscores the importance of early and aggressive interventions designed to bring glucose levels into the normal range regardless of a patients prior diabetes status. The digami study diabetes mellitus insulinglucose infusion in acute myocardial infarction was initiated to test the hypothesis that rapid improvement of metabolic control in diabetic patients with acute myocardial infarction by means of insulinglucose infusion decreases the high initial mortality. Although the value of glucoselowering agents in preventing microvascular complications associated with diabetes has been established, along with reductions in ischemic coronary events, active treatment in one major glycemiccontrol trial. The 1 year mortality was reduced by 30% in the intensively treated group. Management of acute coronary syndrome in special subgroups. Also, the digami population, though modest in size, was larger than had been examined before. Norhammar a, tenerz a, nilsson g, hansten a, efendic s, ryden l, malmberg k. Prognostic implications of hypoglycaemic episodes during. Diabetes mellitus, insulinglucose infusion in acute.
Jun 22, 2002 previously undiagnosed diabetes and impaired glucose tolerance are common in patients with an acute myocardial infarction. Prognostic implications of glucoselowering treatment in. Glucose regulation in acute coronary syndrome the jama network. Randomised trial of insulinglucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction digami study. An increase in updated glucose over the complete study period by 3 mmoll caused a mortality increase of 20%. Hyperglycemia and adverse outcomes in acute coronary. There is now evidence to suggest that achieving glycemic control in patients with diabetes decreases perioperative morbidity and. Randomized trial of insulinglucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction digami study. Prognostic implications of glucoselowering treatment in patients. Patients assigned to the intensive insulininfusion arm received standard insulin and dextrose. Retrospective data from two large scale studies, eur heart j, 10 1989, pp. Objective the present study characterizes mannosebinding lectin mbl, an activator of the complement system and thereby important for inflammatory activation, in patients with diabetes and myocardial infarction.
We searched medline, embase, cochrane central register of controlled trials, chinese biological medicine database, china national knowledge infrastructure, chinese technical periodicals, and wanfang data, up to july 10, 2015, for rcts on insulin and ohas that assessed allcause mortality andor cardiovascular death as primary end points. These patients have higher perioperative morbidity and mortality, significantly reduced longterm survival, and less freedom from recurrent episodes of angina. In a multivariable epidemiological analysis the digami 2 trial clearly confirmed that blood glucose is a strong and independent predictor of longterm mortality following mi in patients with type 2 diabetes. Admission hyperglycemia and acute myocardial infarction. Intensive insulin infusion in infarction study n 240, 47 both investigating the effects of intensive insulin therapy in patients with type 2 diabetes and mishowed no significant effects on mortality in patients at 1 year digami. The digami study demonstrated that intensive insulin therapy reduced allcause mortality in ami patients, but the subsequent digami 2 and hi5 studies did not show this effect. The society of thoracic surgeons practice guideline series.
Intensive versus conventional glucose control in critically. Within the framework of the clinical trial digami 2 hypoglycaemic episodes blood glucose may 12, 2014 intensified insulinbased glycaemic control after acute myocardial infarction in patients with diabetes and hyperglycaemia at admission had a longlasting effect on longevity. Hyperglycaemia and myocardial infarction british journal of. Within the framework of the clinical trial digami 2 hypoglycaemic episodes blood glucose study attempted to rectify some of the issues that were encountered in digami 2.
To explore if hypoglycaemic episodes during hospitalisation influence the subsequent prognosis in patients with diabetes and acute myocardial infarction. The trial is expected to generate discussion in the diabetes. Abstract in patients with diabetes, a complex and controversial relationship exists between intensive glycemic control and cardiovascular cv outcomes. A detailed description of digami including study design, definitions and methods has been given elsewhere. Although the effect of glucose lowering might be less apparent with presently available, more effective lipidlowering and bloodpressurelowering drugs, improved glycaemic control might still be important for longevity. Randomized trial of insulinglucose infusion followed by. Intensive insulin infusion in infarction hi5 study was to determine whether tight glycemic control improves outcomes for hyperglycemic patients with ami. In a retrospective study conducted in 865 trauma and 5234 nontrauma patients mortality in both groups 12%, the relation between hyperglycaemia and mortality was stronger in trauma patients than in other surgical icu patients. The prevalence of hyperglycaemia in critically ill patients approaches 100%. Pdf selfrated health predicts outcome in patients with. Intense metabolic control by means of insulin in patients. The digami study compared conventional antidiabetic therapy to intensive insulin therapy consisting of acute insulin infusion during the early hours of mi and. Mortality prediction in diabetic patients with myocardial. Overall, this study was successful in showing the feasibility and potential advantage of aggressive longterm insulin management in diabetic patients with mis.
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus. Briefly, this is a multicentre, randomised, prospective study on the effect on mortality and morbidity of an intravenous infusion of insulinglucose followed by 4dose subcutaneous insulin therapy given to patients with suspected acute. Pdf fasttrack intense metabolic control by means of insulin in. It improves insulin sensitivity and is helpful especially in. The digami study is a multicenter randomized controlled trial comparing between blood glucose level digami studies, the goal of the hyperglycemia. Diabetic cardiology practical diabetes pdf libribook. The diabetes insulinglucose in acute myocardial infarction digami study changed.
Effect of insulinglucose infusion on mortality following. Effects on allcause mortality and cardiovascular outcomes. While the digami study was able to demonstrate a decrease in both mortality and mean 24hour blood glucose levels, the digami 2 and hi5 studies showed no such signi. A userfriendly, pocketsized reference for all physicians faced with endocrine care and challenges in hospitalized patients, this handbook covers the most common issues leading to an inpatient endocrine consult, providing differential diagnoses, a reasonable and practical approach to investigating and managing the condition, and advice for followup. And now, its connected to the adobe document cloud. Nice recommendations for the management of hyperglycaemia in. Glucose regulation in acute coronary syndrome jama. Publications home of jama and the specialty journals of the.
Adobe acrobat reader dc download free pdf viewer for. The diabetes mellitus, insulin glucose infusion in acute myocardial infarction digami study malmberg et al, 1994. A detailed description of the digami study has been given elsewhere. Role of tight glycemic control during acute coronary.
80 1041 1308 718 400 1073 101 1038 197 712 679 358 590 219 387 779 906 328 1430 1469 381 1274 136 1380 1487 386 473 1107